drugset / Trial / NCT01792739

Lactobacillus Preparation on the Incidence of Diarrhea

NCT01792739 ↗

Phase 4 Unknown 124 enrolled Seoul National University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this trial is to clarify the impact of lactobacillus preparation on the incidence of diarrhea in ICU-admitted patients. Almost all patients in ICU are treated with antibiotics for the effective control of various infections. However, antibiotics-associated diarrhea is another matter of concern. Many previous studies were proved that the use of probiotic lactobacillus preparation can reduce antibiotics-associated diarrhea in ward-admitted patients. In this study, we are planning to perform a similar study in severely ill patients in ICU.

Timeline

Start
2010-11
Primary completion
2013-09
Completion
2013-10

Outcome

Met primary endpoint

paper 7/57 (12%) of the probiotic group developed diarrhoea associated with antibiotic use compared with 19/56 (34%) in the placebo group (P=0.007). PMID 17604300 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus casei variety rhamnosus Unknown 1 g —